Monash Institute of Pharmaceutical Sciences (MIPS)
Post author: Jonathan Baell. Last update: 10/11/2015 at 3:38 pm by Jonathan Baell.
The Australian Translational Medicinal Chemistry Facility (ATMCF) is a purpose-designed, outward-facing, collaborative facility translating new discoveries in disease biology into suitably targeted therapeutics for clinical development.
ATMCF will partner with suitable researchers in disease biology to efficiently and effectively address the multifaceted requirements of drug-discovery.
By working to a suitably defined target product profile (TPP) that addresses an unmet medical need, the complimentary capabilities of the partner and the ATMCF and its other ancillary partners combine to achieve a fully integrated drug discovery platform.
- Organic synthesis.
- Peptide synthesis.
Type: Core facility in a research organisation
Discipline areas: Biological Science, Chemical Science
Affiliations: Monash Institute of Pharmaceutical Sciences, Translating Health Discovery (THD)